Established in 2000, Hindustan Biosciences Limited (HBSL) is an integrated firm with diversified operations in pharmaceutical and biotechnology sectors. The company initially commenced operations by sourcing bulk drugs (APIs) and drug intermediates for the Industry with a wellspring of global suppliers and associates.
In the year 2007 the company obtained the import license from Genetic Engineering Approval Committee (GEAC) for a nephrology product "Recombinant Human Erythropotien" after conducting clinical trials of the same. The company has been marketing the niche drug extensively ever since.
Despite the great advances of medical science and diversified product portfolios there still are a numerous unmet medical needs. In a bid to cater to every one of these nooks and niches in the market Hindustan Biosciences Ltd is now manufacturing and marketing a wide range of premium finished dosage forms of pharmaceutical products.
Hindustan Biosciences Ltd to its credit has world class manufacturing facilities for dry and liquid injectables, liquid/dry syrups, Eye/Ear/Nasal drops, pre-filled syringes and non sterile/sterile ointments, tablets and capsules approved by several regulatory authorities and is trusted by healthcare professionals and patients across the globe.
Committed to serve and promote Integrity, Hindustan Biosciences Ltd operates an ethical and sustainable business that benefits all.